LZTR1 and cancer: The 396 potential disease‐causing LoF LZTR1 variants identified in 111,103 individuals in the non‐cancer gnomAD population were compared to the 64 LoF LZTR1 variants identified in 359 probands (17.8%) that were predicted to be pathogenic in the schwannomatosis cohort.